Company: CERO
Filing Date: 2025-04-01
Form Type: NT 10-K
Source: 0001213900-25-026702
Chunk: 3

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-01
Form: NT 10-K
Chunk 3
---
 of the annual financial statements in a timely
manner. Such expectations and assumptions are inherently subject to uncertainties and contingencies regarding future events and, as such,
are subject to change. Forward-looking statements involve a number of risks, uncertainties or other factors that may cause actual results
or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties
include, but are not limited to, those discussed and identified in public filings made by the Registrant with the Securities and Exchange
Commission (the “SEC”) and the Registrant’s auditors being unable to complete their review of the annual financial statements
in a timely manner and the Registrant consequently not filing the Form 10-K within the time period prescribed in Rule 12b-25 promulgated
under the Securities Exchange Act of 1934.

Any financial results discussed in this document are
preliminary and represent the most current information available to the Registrant’s management as of March 31, 2025, as financial
closing procedures for the fiscal year ended December 31, 2024 are not yet complete. These estimates are not a comprehensive statement
of the Registrant’s financial results for the fiscal year ended December 31, 2024, and actual results may differ materially from
these estimates as a result of the completion of year-end accounting procedures and adjustments, including the execution of the Registrant’s
internal control over financial reporting, the completion of the preparation and audit of the Registrant’s financial statements
and the subsequent occurrence or identification of events prior to the filing of the audited consolidated financial statements for the
fiscal year ended December 31, 2024 in its Annual Report on Form 10-K. In addition, any such statements regarding the Registrant’s
financial performance are not necessarily indicative of the Registrant’s financial performance that may be expected to occur for
the fiscal quarter ending December 31, 2024, or for any future fiscal period.

Should one or more of these risks or uncertainties
materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein. This list
is not exhaustive of the factors that may affect any of the Registrant’s forward-looking statements. Forward-looking statements
are statements about the future and are inherently uncertain, and actual achievements of the Registrant or other future events or conditions
may differ materially from those reflected in the forward-looking statements due to a variety of risks, uncertainties, and other factors,
including without limitation